CAD 1.58
(3.95%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | -279.87 Thousand CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | -100.0% |
2020 | 17.96 Thousand CAD | -98.39% |
2019 | 1.11 Million CAD | -82.37% |
2018 | 6.34 Million CAD | 0.0% |
2017 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 Q2 | - CAD | 100.0% |
2023 Q1 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q2 | 339.05 CAD | -99.9% |
2022 Q4 | - CAD | -100.0% |
2022 FY | - CAD | 0.0% |
2022 Q1 | 339.05 Thousand CAD | -0.7% |
2022 Q3 | 339.05 CAD | 0.0% |
2021 Q1 | 17.96 Thousand CAD | 0.0% |
2021 FY | - CAD | -100.0% |
2021 Q4 | 341.42 Thousand CAD | 0.7% |
2021 Q3 | 339.05 Thousand CAD | 0.0% |
2021 Q2 | 339.05 Thousand CAD | 1786.97% |
2020 Q1 | 1.16 Million CAD | 4.17% |
2020 FY | 17.96 Thousand CAD | -98.39% |
2020 Q4 | 17.96 Thousand CAD | -98.1% |
2020 Q3 | 945.14 Thousand CAD | 1.97% |
2020 Q2 | 926.92 Thousand CAD | -20.47% |
2019 Q4 | 1.11 Million CAD | -0.02% |
2019 Q2 | 1.24 Million CAD | -54.4% |
2019 Q1 | 2.72 Million CAD | -57.03% |
2019 FY | 1.11 Million CAD | -82.37% |
2019 Q3 | 1.11 Million CAD | -10.0% |
2018 Q4 | 6.34 Million CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 FY | 6.34 Million CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aurora Cannabis Inc. | 186.37 Million CAD | 100.15% |
Avicanna Inc. | 4.54 Million CAD | 106.159% |
Avant Brands Inc. | 28.93 Million CAD | 100.967% |
Crescita Therapeutics Inc. | 6.12 Million CAD | 104.569% |
Knight Therapeutics Inc. | 91.83 Million CAD | 100.305% |
MediPharm Labs Corp. | 9.89 Million CAD | 102.827% |
OrganiGram Holdings Inc. | 80.95 Million CAD | 100.346% |
Canopy Growth Corporation | 77.29 Million CAD | 100.362% |
Willow Biosciences Inc. | 221 Thousand CAD | 226.639% |
Auxly Cannabis Group Inc. | 31.42 Million CAD | 100.89% |